Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
Brennan P BergeronHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-4292-2903
Kelly R BarnettHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.
Kashi Raj BhattaraiHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.
Robert J MobleyHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2728-8206
Baranda S HansenCenter for Advanced Genome Engineering, St. Jude Children's Research Hospital, Memphis, TN.
Anthony BrownDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-4408-3998
Kiran KodaliCenter for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN.
Anthony A HighCenter for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN.
Sima JehaHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.
Ching-Hon PuiHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0003-0303-5658
Junmin PengGraduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN.
Shondra M Pruett-MillerGraduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-3793-585X
Daniel SavicHematological Malignancies Program, St. Jude Children's Research Hospital, Memphis, TN.
St. Jude Children's Research Hospital · US
Funding
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Characterizing noncoding GWAS variants in acute lymphoblastic leukemia treatment outcomeR01CA234490 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SAVIC, DANIEL · 2019 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. · full record | OpenQuestion